Vobarilizumab 沃巴利珠单抗,仅用于工业应用或科学研究,不可用于人类或动物的临床诊断或治疗,非药用. Vobarilizumab (ALX-0061) is an anti-IL-6R monoclonal antibody (mAb) (Kd: 0.19 pM). Vobarilizumab consist
(20A11-9mer-ALB11),ALX-0061 靶点;物种(Specificity target name;species) ALB/IL6R/CD126 [Homo sapiens] 种类(Species) Humanized 受体鉴定(Receptor identification) VH-VH' 化学信息 CAS 1628814-88-9 存储条件(Storage) Use a manual defrost freezer and avoid repeated freeze-thaw cycl...
vobarilizumab (ALX-0061, sc alx-0061, subcutaneous alx-0061) - BioCentury Product Profiles for the biopharma industry
0061 treatment arms only), and who achieved at least 20% improvement in swollen joint count (SJC) and/or tender joint count (TJC) (66/68 counts) compared to Baseline at the final visit of the preceding study (i.e., Week 24 for Study ALX0061-C201 and Week 12 for Study ALX0061-C202...
Bispecific, (20A11-9mer-ALB11), ALX-0061, CAS: 1628814-88-9 Note For research use only. Not suitable for clinical or therapeutic use. 关键字:Vobarilizumab;DHC36906;CD126, IL-6R 1; 公司简介 武汉佰乐博生物(Biolab Reagents)由五位毕业于华中科技大学,华中农业大学,武汉大学等知名高校,且具有二...
Alternative Names: ALX 0061 Latest Information Update: 05 Nov 2023 Price : €55 * Buy Profile Note: Adis is an information provider. We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing address. Your purchase entitles...